Clinical Trials on Platelet-Rich Plasma

Total 5635 results

Kaiser Franz Josef Hospital

Completed

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry (IDEAL-PCI)

Coronary Stent Implantation | Platelet Inhibition

Austria
Universitätsklinikum Hamburg-Eppendorf

Completed

Low-dose Acetylsalicylic Acid Before Non-cardiac Surgery

Surgery | Platelet Dysfunction

Germany
Centre Hospitalier Universitaire de Besancon

Completed

Retrospective Descriptive Study of Platelet Transfusion in Patients With Palliative Hematologic Malignancies at the University Hospital of Besançon

Palliative Care | Platelet Transfusion

France
Bloodworks

Unknown

Cold Apheresis Platelets in PAS (CAPP)

Platelet Transfusion

United States
University of Patras

Completed

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

Platelet Reactivity

Greece
AstraZeneca

Completed

Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels

Safety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and Tmax

United Kingdom
IRCCS Centro di Riferimento Oncologico della Basilicata
Celgene Corporation

Completed

Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia

Primary Plasma Cell Leukemia

Italy
Rennes University Hospital

Completed

TPE in Rennes Hospital (COMPLASMA)

Therapeutic Plasma Exchange

France
PepsiCo Global R&D

Completed

Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers

Plasma Caffeine Concentration

United States
Nanyang Technological University

Completed

Nitrate and Power Output After Two Beetroot Juice Drinks

Blood Plasma Nitrite

Singapore
Cliniques universitaires Saint-Luc- Université...

Completed

IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.

Therapeutic Plasma Exchange

Belgium
B. Braun Melsungen AG

Completed

Safety Profile of Hydroxyethyl Starch

Plasma Volume Replacement

Malaysia, China
Shandong University
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences; Shenzhen Second People's Hospital and other collaborators

Completed

A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP

Thrombocytopenia

China
Stanford University

Completed

Effects of a Platelet Transfusion Best Practices Alert

Thrombocytopenia

United States
Maastricht University Medical Center

Completed

Post-Operative Thrombocytopenia After Bio-prosthesis Implantation (PORTRAIT)

Thrombocytopenia

Netherlands
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Completed

American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)

Thrombocytopenia

United States
The First Affiliated Hospital of Soochow University
Peking University People's Hospital; Qilu Hospital of Shandong University; Nanfang... and other collaborators

Completed

Prospective Study of Patients With Thrombocytopenia Following HSCT

Hematologic Diseases | Thrombocytopenia

China
First Affiliated Hospital Xi'an Jiaotong University
Shenyang Pharmaceutical University

Unknown

High-dose Use of rhTPO in CIT Patients (HUrhTPOCITP)

Thrombocytopenia

China
Sanquin Research & Blood Bank Divisions
Terumo BCT

Completed

Pathogen Reduction Evaluation & Predictive Analytical Rating Score (PREPAReS)

Thrombocytopenia

Netherlands, Norway, Canada
Massachusetts General Hospital
GlaxoSmithKline

Terminated

Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

Coronary Artery Bypass Graft Surgery | Presence of Heparin/Platelet Factor 4 Antibody

United States
University of Oklahoma

Completed

Study of the Effect of Differing Platelet Transfusion Times in Neonates

Thrombocytopenia

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
National Cancer Institute (NCI)

Completed

Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Terminated

Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Refractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell Myeloma

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Completed

Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Shifa Ul Mulk Memorial Hospital

Recruiting

Effect of Herbal Formulation on Thrombocytes Count

Thrombocytopenia

Pakistan
Institute of Liver and Biliary Sciences, India

Recruiting

Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation

Thrombocytopenia

India
Centre Hospitalier Universitaire de Saint Etienne

Completed

Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic (TITIM)

Thrombocytopenia

France
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. (ITP0511)

Thrombocytopenia

Italy
Sobi, Inc.

Terminated

Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure

Thrombocytopenia

United States
University of Cincinnati
GlaxoSmithKline

Withdrawn

Study of Eltrombopag in Platelet Refractory Thrombocytopenia

Thrombocytopenia

United States
Seoul National University Hospital

Completed

Remote Ischemic Conditioning and Platelet Dysfunction

Platelet Function

Korea, Republic of
Socrates School Of Health

Completed

Thrombocytopenia Induced by Chemotherapy (papayaleaf)

Thrombocytopenia

India
Eisai Inc.

Completed

A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects

Thrombocytopenia

United States
Medstar Health Research Institute

Completed

Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine (PLACID)

Bleeding | Platelet Aggregation

United States
National Institutes of Health Clinical Center (CC)

Completed

Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus

Thrombocytopenia

United States
Assiut University

Not yet recruiting

Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients

Thrombocytopenia
Medical University Innsbruck

Completed

Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG) (PAC)

Inflammatory Response | Cardiopulmonary Bypass | Platelet Dysfunction

Austria
IRCCS Policlinico S. Donato

Completed

PLATelet Function Operating Room Monitoring (PLATFORM)

Bleeding | Platelet Dysfunction Due to Drugs

Italy
Nantes University Hospital

Completed

Romiplostim in Thoracic Transplantation (N-PLATE)

Thrombocytopenia
Terumo BCTbio

Terminated

Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study) (PRESS)

Thrombocytopenia

Denmark
National Cerebral and Cardiovascular Center

Completed

The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients

Platelet Aggregation Inhibitors
University of Patras

Completed

Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.

Platelet Reactivity

Greece
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

Thrombocytopenia

China
Northwell Health
Staten Island University Hospital

Completed

Effect of Hemodialysis Membranes on Platelet Count

Thrombocytopenia

United States
Christiana Care Health Services
Thomas Jefferson University; Alfred I. duPont Hospital for Children; Abington...

Completed

Transfusing Neonates Based on Platelet Mass

Thrombocytopenia

United States
Cerus Corporation

Completed

Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days (TESSI)

Thrombocytopenia

United Kingdom
Terumo BCTbio

Completed

Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products

Thrombocytopenia

France
Christiana Care Health Services

Completed

Thrombopoietin Levels and Platelet Transfusion in Neonates

Thrombocytopenia

United States

Clinical Trials on Platelet-Rich Plasma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations